PRO1107 in Patients With Advanced Solid Tumors
Genmab
Genmab
Accent Therapeutics
Pheon Therapeutics
M.D. Anderson Cancer Center
Seagen Inc.
Fusion Pharmaceuticals Inc.
Blueprint Medicines Corporation
Alaunos Therapeutics
Artios Pharma Ltd
Tempus AI
Incyte Corporation
Virginia Commonwealth University
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
Bolt Biotherapeutics, Inc.
Pfizer
Bio-Thera Solutions
University Health Network, Toronto
Alaunos Therapeutics
NuCana plc
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
University of Maryland, Baltimore
Dana-Farber Cancer Institute
University of Oklahoma
Pfizer
Stanford University
University of Oklahoma
Columbia University
Ohio State University Comprehensive Cancer Center
Seagen Inc.
Seagen Inc.
Fox Chase Cancer Center
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Elucida Oncology
Wake Forest University Health Sciences
Henry Ford Health System
Haihe Biopharma Co., Ltd.
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
Sunnybrook Health Sciences Centre
pharmaand GmbH
Fate Therapeutics
University of Iowa
Xenetic Biosciences, Inc.
Zai Lab (Hong Kong), Ltd.
Novartis
PharmaMar
University of Chicago